About Arista Biologicals
Founded in 1993, Arista Biologicals, a Fortis Life Science company, develops diagnostic reagents for in vitro diagnostic and research applications. The company specialises in highly characterised antibodies, antigens and control materials used in immunoassay development. Its expertise includes reagent selection, conjugation technologies and assay optimisation for lateral flow and point-of-care diagnostic platforms. These capabilities support the development of reliable tests for infectious diseases, fertility monitoring, toxicology screening and other clinical diagnostic applications. By providing well-characterised biological materials, Arista Biologicals helps researchers and assay developers improve analytical performance and reproducibility throughout the diagnostic workflow.
Arista Biologicals offers a portfolio of antibodies, antigens, assay controls and custom diagnostic components designed for immunodiagnostic applications. The company also provides conjugation and assay development services that support the creation and validation of rapid tests and lateral flow assays. Its products are used in assay design, verification, manufacturing and quality control processes across clinical and commercial diagnostic programmes. Through its focus on immunodiagnostic reagents and assay development expertise, Arista Biologicals supports laboratories and diagnostic manufacturers working to translate biological targets into robust testing platforms.
Europa Biosite’s subsidiaries distribute for Arista Biologicals in Belgium, Denmark, Estonia, Finland, Iceland, Ireland, Latvia, Lithuania, Luxembourg, Netherlands, Norway, Sweden, Switzerland and the United Kingdom.